Flap endonuclease-1 (FEN-1), a 43-kDa protein, is a structure-specific and multifunctional nuclease. It plays important roles in RNA primer removal of Okazaki fragments during DNA replication, DNA base excision repair, and maintenance of genome stability. Three functional motifs of the enzyme were proposed to be responsible for its nuclease activities, interaction with proliferating cell nuclear antigen, and nuclear localization. In this study, we demonstrate in HeLa cells that a signal located at the C terminus (the nuclear localization signal (NLS) motif) facilitates nuclear localization of the enzyme during S phase of the cell cycle and in response to DNA damage. Truncation of the NLS motif prevents migration of the protein from the cytoplasm to the nucleus, while having no effect on the nuclease activities and its proliferating cell nuclear antigen interaction capability. Site-directed mutagenesis further revealed that a mutation of the KRK cluster to three alanine residues completely blocked the localization of FEN-1 into the nucleus, whereas mutagenesis of the KKK cluster led to a partial defect of nuclear localization in HeLa cells without observable phenotype in yeast. Therefore, the KRKXXXXXXXXKKK motif may be a bipartite NLS driving the protein into nuclei. Yeast RAD27⌬ cells transformed with human mutant M krk survived poorly upon methyl methanesulfonate treatment or when they were incubated at an elevated temperature.
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DNA replication and repair are critical for maintaining genome stability. These processes are in part dependent on the activity of an emerging family of structure-specific endonucleases. These enzymes, typified by flap endonuclease-1 (FEN-1), 1 are multifunctional. They possess both flap-specific endo-and nick-specific exo(ribo)nuclease activities and interact with proliferating cell nuclear antigen (PCNA) (1) (2) (3) (4) (5) (6) (7) (8) . FEN-1 is required for the removal of both RNA primers during lagging strand DNA synthesis and damaged DNA fragments in the long patch DNA base excision repair pathway (9 -14) . The fact that FEN-1 is critical for preserving the integrity of a genome is underscored by recent work showing that RAD27 (FEN-1 homologue) null mutants in Saccharomyces cerevisiae have a strong mutator phenotype. This phenotype is a result of duplication mutations arising from the inability of the cells to process correctly the RNA primers associated with Okazaki fragments during lagging strand DNA replication (15) . Duplication mutations are associated with several human disorders such as recessive retinitis pigmentosa, lethal junctional epidermolysis bullosa, familial hypertropic cardiomyopathy, and various cancers. In addition, FEN-1 helps to prevent trinucleotide repeat expansion and contraction, as a deletion of RAD27 in S. cerevisiae results in length-dependent destabilization of CTG tracts and a marked increase in expansion frequency (16, 17) . Trinucleotide expansions are involved in genetic diseases such as myotonic dystrophy, Huntington's disease, ataxias, and fragile X syndrome.
Nuclear localization is an important component of the ability of the cell to regulate DNA replication, repair, and other biological functions. Transport occurs through the nuclear pore complex (18, 19) . The nuclear pore allows small molecules to diffuse freely into and out of the nucleus (18, 19) . Targeting of larger proteins to the nucleus usually requires the presence of a nuclear localization signal (NLS) (19) . A variety of proteins such as heat shock protein factor 2, p53, transcription factors, DNA repair complex hRad51/BRCA1, and xeroderma pigmentosum group G (XPG) nuclease have a nuclear localization signal (20 -26) . Two major types of NLSs are recognized as follows: 1) a single cluster of basic amino acids, exemplified by the SV40 T antigen NLS; and 2) a bipartite NLS composed of one cluster of two basic amino acids, a spacer region of 10 -12 amino acids, followed by another basic cluster, as found in nucleoplasmin (18, 27) .
To function, DNA replication and repair proteins have to migrate into the nucleus after they are translated in the cytoplasm since their target DNA substrates are located in nucleus. Previously identified NLSs in DNA repair proteins are bipartite (28) . Mutations of the NLS motif may not only alter regulation of protein movement but also affect their cellular functions, which in humans may cause diseases. The NLS of the DNA repair protein XPG resides in the C-terminal region (amino acid residues 1164 -1185) and is essential for the formation of foci and for response to UV damage (22, 29) . The distribution of XPG proteins could also regulate the rate of DNA repair within transcriptionally active and inactive compartments of the cell nucleus. Recently, the NLS of mammalian DNA replication ligase (ligase I) has been identified at residues 119 -131 (30) . In addition, the enzyme has an additional motif of ϳ20 amino acids at their N terminus, which functions as a replication factory targeting sequence. This motif, consisting of two clusters of bulky and positively charged residues, is necessary and sufficient for the interaction with proliferating cell nuclear antigen (PCNA). DNA ligase I is recruited to sites of DNA replication by an interaction with PCNA.
It was proposed that there are three motifs of the FEN-1 nuclease responsible for three distinct functions as follows: nuclease activities, PCNA interaction, and nuclear localization (1, 4, 31) . The C-terminal 26 amino acids of hFEN-1 are basic and conserved in the FEN-1/XPG family and may be involved in nuclear localization (31) . In this study, we demonstrate that FEN-1 nuclease localizes into the nucleus in a cell cycle-dependent manner and in response to DNA damage in human HeLa cells. Truncational and site-directed mutagenesis in the C-terminal NLS motif was carried out for in vitro and in vivo functional analysis in both mammalian and yeast cells. Truncation of the signal domain effectively blocked nuclear localization in vivo but had no effect on nuclease activity and PCNA interaction in vitro. Site-directed mutagenesis revealed that KRKXXXXXXXXKKK is a bipartite NLS since substitution of KRK with alanines completely eliminate the nuclear localization, whereas KKK mutagenesis partially abolishes the function. An NLS-defective FEN-1 transformed into yeast null mutant cells resulted in an increased sensitivity to methyl methanesulfonate (MMS) treatment and slower growth at an elevated temperature. These results indicate that the NLS is essential to the FEN-1-dependent cellular responses to environmental stresses.
EXPERIMENTAL PROCEDURES

Materials
Oligonucleotide primers were synthesized at the City of Hope Cancer Center core facility. Sources of plasmid vectors used in this study for subcloning, mutagenesis, and expression are detailed below. Quickchange site-directed mutagenesis kit, PCR-cloning kit, and Escherichia coli strain XL1 blue competent cells were purchased from Stratagene (La Jolla, CA). Restriction enzymes were obtained from New England Biolabs (Beverly, MA). [␣Ϫ 32 P]dCTP was purchased from PerkinElmer Life Sciences. Polyclonal antibody against human FEN-1 protein was custom-produced at Research Genetics, Inc. (Huntsville, AL). The anti-FEN-1 serum was collected from a rabbit after three boosts and stored at Ϫ80°C. Monoclonal antibody against human FEN-1 protein was purchased from Novus (Littleton, CO). Secondary antibody was from Santa Cruz Biotechnology (Santa Cruz, CA). Nylon membrane was purchased from Schleicher & Schuell. Fast purification liquid chromatography accessories and reagents were from Amersham Pharmacia Biotech. Yeast culture media, including YPD, synthetic complete (SC), minimal sporulation, and synthetic dextrose minimal (SD), were prepared according to Sherman et al. (32) . Cell cycle inhibitors (mimosine and nocodazole), amino acids, and all other chemicals were purchased from Sigma.
cDNA, Plasmids, and Mutagenesis
cDNA for human FEN-1 was the laboratory stock as described previously (33) . Vectors for expression, subcloning, and mutagenesis included pBSK (Stratagene, La Jolla, CA) for subcloning and mutagenesis, pEGFP-N1 N-terminal protein fusion vector (CLONTECH, Palo Alto, CA) for the expression of FEN-1 proteins fused with GFP in human cells, and pET-28b (Novagen, Madison, WI) for protein overexpression in E. coli. The pBSK plasmid with the insertion of wild type FEN-1 was used for site-directed mutagenesis to give rise to the following three mutants. M krk has the mutation of KRK at residues 354 -356 to AAA using the primers 5ЈGCTCACTCTCTTCAGCTGCGGCTGCTG-AGCCAGAACCCAAGG3Ј and 5ЈCCTTGGGTTCTGGCTCAGCAGCCG-CAGCTGAAGAGAGTGAGC3Ј. M kkk has the mutation of KKK at the residues 365-367 to AAA (KKK/AAA) using the primers 5ЈACCCAAG-GGATCCACTGCTGCTGCTGCAAAGACTGGGGCAG3Ј and 5ЈCTGCC-CCAGTCTTTGCAGCAGCAGCAGTGGATCCCTTGGGT3Ј. The third mutant M kr has mutation of KR at residues 378 and 379 to AA using the primers 5ЈGGCAGCAGGGAAGTTTGCAGCGGGAAAAAGCTTTATTA-AA3Ј and TTTAATAAAGCTTTTTCCCGCTGCAAACTTCCCTGCTGC-C3Ј. To determine the localization pattern of the FEN-1 proteins in human cells, we amplified DNA fragments of the wild type FEN-1 and the three site-directed mutants M kkk , M krk , and M kr using PCR based on primers, CK01-5ЈCCTCTGTGCTAGCATGGGAATTCAAGGCC3Ј and CK02a-5ЈCCTCTCCAAGCTTTCCCCTTTTAAACTTCC3Ј (sequences for desired restriction sites are underlined). These fragments were then subcloned into the pEGFP-N1 vector, respectively, at the NheI and HindIII sites. An NLS-truncated FEN-1 cDNA construct (M nlsd ) was also generated using the primer pair of CK01 and CK03a, 5ЈCCTCTC-CAAGCTTGAAGAAATCATCCAG3Ј, and then cloned into pEGFP-N1 vector also at the NheI and HindIII sites. To observe the biological functions of the FEN-1 proteins in yeast, DNA fragments of the wild type FEN-1, M kkk , M krk , and M kr cDNA were directly derived from pBSK-based plasmids using the restriction enzyme NotI. They were then cloned into the yeast expression vector, pDB20. The truncation mutant M nlsd DNA was PCR-amplified using primers T7 and NLSD-NOT (5ЈACACACAGCGGCCGCTTACTTGAAGAAATCATCCAG) and then subcloned into pDB20 at the NotI site. For bacterial overexpression of FEN-1 proteins, the full-length wild type human FEN-1 coding sequence was previously subcloned into pET-28b vector (33) . DNA fragments of mutants M krk , M kkk , and M kr from the pBSK-based constructs were excised using NcoI and XhoI and were subcloned into pET28b. For the construction of pET28b plasmid of the NLS-truncated mutant, a DNA fragment of the mutant was amplified using primers T7 and CK03a and was subcloned into pET28b at the NcoI and XhoI sites.
Overexpression and Purification of FEN-1 NLS Mutants
Truncated and site-directed NLS mutant proteins overexpressed in bacteria were less soluble than wild type FEN-1 protein, and a majority of the protein was located in the inclusion bodies. We overcame this problem by optimizing bacterial expression conditions. Specifically, the bacterial cells were cultured in 70% Luria broth at 30°C for higher solubility of the FEN-1 protein in vivo. Once the protein was solubilized, they were purified as described previously (34) . Briefly, the lysate was sonicated (Branson Sonifier 450, Branson Ultrasonics) and centrifuged at 15,000 ϫ g for 45 min to remove the cell debris. A 5-ml HiTrap chelating Ni 2ϩ column was equilibrated with buffer A using fast purification liquid chromatography system (Amersham Pharmacia Biotech). After loading, the column was washed with 25 ml of buffer A and 25 ml of buffer A plus 60 mM imidazole and was eluted with a 50-ml linear gradient from 60 -500 mM imidazole in buffer A at 2 ml/min. The fractions were run on a 10% SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue R-250. The buffers of the fractions were exchanged to 10 mM Tris-HCl, 150 mM NaCl, pH 8.0, by a HiTrap desalting column. Protein concentrations were determined using the Bio-Rad protein assay.
Biochemical Assays
Assays for flap endonuclease and nick-specific exonuclease activities were carried out as described previously (31) . The following oligonucleotides were used to make the flap and nicked DNA substrates: a template strand (5ЈGGACTCTGCCTCAAGACGGTAGTCAACGTG), a 5Ј-labeled flap strand (5ЈGATGTCAAGCAGTCCTAACTTTGAGGCAG AGTCC-3Ј), and an adjacent strand (5ЈCACGTTGACTACCGTC) for the flap DNA substrate; for the exonuclease DNA substrate, a 5Ј-labeled downstream strand 5ЈTTGAGGCAGAGTCC3Ј was employed instead of the flap strand in the flap substrate. The reactions were performed in a mixture containing 0.8 pmol of [ 32 P]DNA, 50 mM Tris-HCl, pH 8.0, 10 mM MgCl 2 , and 30 ng of enzyme in 13 l at 30°C for 30 min. The reactions were stopped by adding 3 l of stop solution (U. S. Biochemical Corp.), boiled for 3 min, and then cooled in ice. 4 l of each reaction product was run on a 15% denaturing polyacrylamide gel. The gel was exposed to Kodak x-ray film. For PCNA interaction analysis, E. coli cell crude extracts of His-tagged proteins of wild type FEN-1 and NLS mutants were individually mixed with crude extracts of BL21(DE3)/pT7/ PCNA expressing PCNA without a His tag (5, 35) . The mixture was loaded onto a Amersham Pharmacia Biotech nickel column, washed, and eluted with 500 mM imidazole. The eluates were run on a 10% SDS gel to examine the interaction of PCNA and NLS mutant FEN-1 proteins.
Cell Culture, Transfection with FEN-1/GFP Fusion Constructs, and MMS Treatment-HeLa cells (laboratory stock) were cultured in Dulbecco's modified Eagle's medium plus 10% fetal bovine serum, 100 units/ml penicillin, and 0.1 mg/ml streptomycin at 37°C with 5% CO 2 . The cells were passaged until the day before transfection. When cells achieved 60% of confluency, they were individually transfected with the plasmid DNAs as follows: wild type FEN-1, M nlsd , M krk , M kkk , M kr , and pEGFP N-1, with the FuGENE6 reagent (Roche Molecular Biochemicals). After transfection, the cells were cultured for 24 h and then washed with PBS and fixed with 4% formaldehyde for 15 min at room temperature. After a final wash with PBS, the cells were mounted with glycerol. GFP fluorescence signals in transfected cells were detected with an Olympus fluorescence microscope using a 495-nm filter. To assess the nuclear localization response to DNA damage, cells released from nocodazole inhibition at G 2 phase (see below) were treated with 150 M MMS. Treated cells harvested at the different time intervals were observed for the status of nuclear localization under a fluorescent microscope, and the results were recorded. Nuclear proteins were analyzed by Western blotting (see below for details).
Cell Cycle Synchronization and Flow Cytometry
HeLa cells were synchronized at the G 1 /S boundary using mimosine and at the G 2 /M boundary using nocodazole as described previously (36 -38) . Synchronization in G 1 was achieved by serum starvation to 0.2% fetal bovine serum for 24 h. The cells were then re-fed in the complete medium supplemented with mimosine (200 M, final concentration) for 24 h. To release cells into S phase, the cells were incubated in mimosine-free medium. Synchronization in G 2 was achieved by culturing cells with 40 ng/ml nocodazole (final concentration) in complete medium for 12 h. After removal of drugs, the cells were harvested at different time points. The cell cycle phase distribution of a cell population was determined by measuring cell DNA contents in different phases by flow cytometry. To prepare cell samples for flow cytometry, cells (1 ϫ 10 6 ) were resuspended in complete medium after trypsinization, pelleted by centrifugation at 500 ϫ g, resuspended in PBS, and then repelleted. The cells were fixed in 75% cold ethanol and stored at 4°C. Immediately prior to flow cytometric analysis, the samples were treated with RNase A for 30 min at room temperature and then stained with propidium iodide (50 g/ml, final concentration) overnight. The samples were analyzed by using a MoFlo FACS (Cytomation, Inc., Fort Collins, CO).
Nuclear Protein Extraction and Western Blotting Analysis
The HeLa cells (2 ϫ 10 7 ) treated with MMS (150 M, final concentration) were harvested by scraping cells with a rubber policeman and transferred to a 1.5-ml microcentrifuge tube. The nuclei were first isolated from cells based on the protocol described by Docherty (39) . Briefly, the cells were pelleted, washed, and resuspended in 400 l of HEPES buffer (10 mM, pH 7.9) with 10 mM KCl and 1ϫ protease inhibitor mixture on ice for 15 min. Then 25 l of 10% Nonidet P-40 solution was added, the suspension vortexed vigorously for 15 s, and centrifuged for 30 s at 15,000 ϫ g. To disrupt the nuclear membrane and extract the nuclear proteins, the pellet was resuspended in 10 volumes of RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% NaDoC, 0.1% SDS, 50 mM Tris, pH 8.0, 1ϫ protease inhibitor mixture) at 4°C for 30 min. After centrifuging for 20 min at 4°C, the supernatant was collected and transferred to a fresh tube. 10 g of nuclear protein was separated on 10% SDS-PAGE. To visualize uniform loading of nucleic protein extracts taken from different time points, the gel was cut into halves. The upper part was silver-stained (Bio-Rad), and the proteins on the lower part of the gel were electrophoretically transferred to a nitrocellulose membrane for use in Western blotting. The membrane was blocked with 5% nonfat dry milk in TBST (25 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Tween 20) for 1 h at room temperature and then probed with anti-FEN-1 polyclonal antibody (1:4,000) or monoclonal antibody (1:1000) for 2 h at 4°C. After washing with TBST, the membrane was incubated with peroxidase-conjugated goat anti-rabbit antibody (1:5,000). The Western blotting image was visualized by the Pierce chemiluminescence detection system (Pierce).
Immunofluorescent and PI Staining and Microscopy
HeLa cells were cultured in glass chamber slides (Fisher) coated with 0.01% poly-L-lysine (Sigma). Cells were fixed in 4% formaldehyde for 15 min at room temperature and washed with PBS. They were then incubated with anti-FEN-1 polyclonal antibody (1:50) for 1 h at room temperature. After washing with PBS, cells were incubated with a fluorescein isothiocyanate (FITC)-conjugated anti-rabbit polyclonal antibody (1:50) for 1 h. The cells were also stained with 0.5% propidium iodide (PI) to visualize nuclei. After washing with PBS, they were then mounted in 90% glycerol/PBS. FEN-1 protein signals and nuclei were observed and recorded with an Olympus fluorescence microscope (Olympus, Japan).
Yeast Manipulation, Growth Curves, and DNA Damage/Repair Analysis
Six constructs including pDB20 plasmid with no insert and pDB20-based plasmids with FEN-1 wild type or different NLS mutants were transformed into two isogenic yeast strains F3C-15B (wild type) and IC2-1 (the rad27 null mutant), respectively (40) . The null mutant displayed a distinctive phenotype due to defects in the DNA replication and repair pathways. Transformants were selected using SD-URA plates. Nine strains were chosen and grown in SD-URA liquid medium to saturation at 30°C. Cell density was measured with a spectrophotometer at 600 nm and diluted in water if necessary.
Observation of Cell Growth-The concentration of nine strains was standardized to OD value of 1.5 (ϳ3 ϫ 10 7 cells per ml). For growth curves, 100 l of cells of each standardized strain was grown in 8 ml of SD-URA liquid medium at both 30 and 37°C. OD values were then measured at 5, 10, 15, and 22 h. The growth curves were plotted using the average OD values of triplicate experiments versus culture time. Different yeast strains were diluted 1, 5, 25, 125, and 625 times and grown on SD-URA plates at both 30 and 37°C. One microliter of each dilutant was plated on the medium as a dot as shown in the figures.
MMS Treatment-For each density-standardized strain, 500 l of cells were used for MMS treatment. Cells were centrifuged and washed with water and then treated with 500 l of 0.05 or 0.1% MMS in 0.1 M potassium phosphate buffer, pH 7.0, for 30 min. The treated cells were washed with 1.5 ml of water three times and suspended in water in a final volume of 500 l. The samples were further diluted 8,000 times for the control (without MMS treatment), 2,000 times for 0.05% MMS treatment, and 1,000 times for 0.1% MMS treatment. 100 l of cells were plated on SD-URA and cultured at 30°C. After 4 days, colonies were observed and counted. Survival rate was determined based on the ratio of colony counts with MMS to colony counts without MMS treatment. Survival histograms represent the mean from at least two independent experiments. In addition, the observation of MMS sensitivity of different strains with various dilutions on plates was made on SD-URA with 0.05% MMS. Five dilutions, 1, 5, 25, 125, and 625 times, were made for each sample. One microliter of each diluent was plated as a dot on a SD-URA plate. Samples were observed and photographed after 5 days of incubation at 30°C. human enzyme, cell cycle phases were first determined by flow cytometry based on relative fluorescence represented on the x axis and cell number represented on the y axis of the flow cytometric profiles (Fig. 1A) . After removal of mimosine (an inhibitor of DNA replication forks), cells entered the S phase and underwent a period of high DNA synthesis (0 -6 h after release corresponding to S phase), followed by G 2 phase (8 -15 h after release). G 2 phase-synchronized cells were obtained by nocodazole inhibition (Fig. 1A) . FEN-1 protein signals were detected at 0, 3, 6, 10, and 13 h after G 1 release as well as at a time immediately after G 2 release (Fig. 1B) . Both cytoplasmic and nuclear immunostainings were observed when cells were immediately released from the G 1 /S boundary and G 2 phase (Fig. 1B, 0 h and G2) . The FEN-1 protein clearly moved to and localized in nuclei 3 and 6 h after mimosine release, which corresponds to S phase (Fig. 1B) . The fact that FEN-1 protein was localized into the nuclei in S phase is in agreement with the role of FEN-1 nuclease in DNA replication. When cells entered G 2 phase, FEN-1 nuclease migrated back to cytoplasm (Fig. 1B, 10 and 13 h) . Fig. 1C is the PI staining to visualize the nuclei in cell cycle phases corresponding to the ones in Fig. 1B .
RESULTS
FEN-1 Nuclease Is Localized into the
Nuclear Localization of FEN-1 Nuclease Is DNA Damageinducible-A critical function of FEN-1 nuclease is its structure-specific endonuclease activity in an alternative long patch DNA base excision repair pathway (13, 14) . We hypothesized that the nuclear localization of FEN-1 nuclease is inducible upon DNA damage. Cells in G 2 were chosen for this experiment because earlier experiments (Fig. 1) showed that the FEN-1 protein was distributed in the cytoplasm and nucleus during this stage. Cells were fixed at several different time points after MMS treatment. Following initial treatment with MMS, FEN-1 signals were observed in perinuclei after 10 min (Fig. 2,  10 min ). FEN-1 was then localized in nuclei after 20 min and thereafter (Fig. 2, 20 and 40 min, and 1.5, 3, and 5 h) . To semi-quantitatively determine nuclear localization of FEN-1 protein upon MMS treatment, Western blotting of nuclear proteins isolated from MMS-treated cells was performed. Cells treated with 150 M MMS were harvested at different time points as indicated. Nuclei were isolated, and nuclear proteins were solubilized and separated on a SDS-PAGE gel. The upper part of the gel was silver-stained to inspect the normalization of the protein sample loading (Fig. 3A, lower panel) . The FEN-1 peptide represented in the lower part of the gel was visualized by Western blotting (Fig. 3A, upper panel) . The relative intensities of FEN-1 from different time points in the Western blotting were normalized to the marked band in the silver-staining gel and are shown in Fig. 3B . The nuclear FEN-1 level increased ϳ10-fold soon after MMS treatment (Fig. 3B) .
The NLS of FEN-1 Is Not Required for Nuclease Activity nor Its Interaction with PCNA in Vitro-
The NLS C-terminal 26-amino acid motif of the FEN-1 nuclease only exists in eukaryotic enzymes but not in their prokaryotic homologues. There are three clusters of positively charged amino acid residues in this region, which may be important for nuclear localization (31) (Fig. 4A) . These amino acids are KRK (residues 354 -356), KKK (residues 365-367), and KR (residues 377-378), and all were converted to alanines in this study to test their role in nuclear localization. In addition, a truncated version of FEN-1 without the last 26 amino acids was tested. The four mutant versions and wild type FEN-1 proteins were overexpressed in bacteria and purified (Fig. 4B) . By using purified proteins, flap endonuclease and exonuclease assays were performed using different DNA substrates as described under "Experimental Procedures." No significant difference in enzyme activities was observed between the NLS-truncated mutant enzyme and wild type (Fig. 5, A and B) . The experiments were repeated independently with the point mutant enzymes (M kkk , M krk , and M kr , data not shown). FEN-1/PCNA interaction experiments were also performed and showed that both wild type and NLS mutant proteins could bind to PCNA without any observable defect (Fig. 5C) .
Deletion or Mutations of the NLS Motif Abolishes the Nuclear Localization of FEN-1-
The role of the NLS in nuclear targeting was tested by using wild type and NLS mutant FEN-1 coding regions fused to GFP. The expression of the FEN-1/GFP fusion protein was under control of the P CMV lE promoter. Fig.  6 shows that wild type (Fig. 6b ) and M kr (Fig. 6c) human FEN-1 fused with GFP were able to localize into nuclei. However, conversion of amino acids KRK to alanines or deletion of the whole NLS motif (Fig. 6 , e and f) completely abolished nuclear localization. The mutant M kkk was still able to drive inefficiently the fusion protein into the nucleus (Fig. 6d) . From these data, we conclude that the bipartite sequence KRKXXXXXXX-XKKK is an NLS for FEN-1 nuclease.
Biological Deficiency of NLS Mutants in DNA Replication and Repair-We performed two experiments to investigate the effects of NLS mutants of FEN-1 on cellular DNA replication and repair. The human wild type FEN-1 and three site-directed NLS mutant FEN-1 genes were used to transform into yeast. We expressed the human proteins in yeast wild type and rad27 null mutant strains, the latter showing conditional lethality and MMS sensitivity due to defective RNA primer removal and long patch DNA base excision repair. Our previous studies demonstrated that functional FEN-1 can complement a rad27 null (40) . All of the strains were individually transformed with the vector alone (pDB), and wild type and mutant FEN-1 genes M krk , M kkk , and M kr can grow at 30°C in both wild type and rad27 null backgrounds. However, the growth of a rad27 null mutant transformed with pDB and pDB/M krk was significantly retarded at 30°C (Fig. 7A, lanes 6 and 9) . When the duplicated plate was incubated at 37°C, the rad27 null strains could survive when they were transformed with wild type, M kkk , and M kr FEN-1 expression plasmids (Fig. 7B, lanes 5, 7, and 8) . Null mutant cells proliferated much slower when they were transformed with NLS- defective FEN-1s (Fig. 7B, lanes 6 and  9) . The growth curves displayed in Fig. 7C showed quantitatively similar results to Fig. 7B when cells were grown in liquid medium at 37°C.
To test the complementation of MMS hypersensitivity in the rad27 null strain transformed with a human NLS mutant FEN-1s, we measured the cell survival rates after MMS treatment. Five dilutions of each strain were plated onto YPD medium containing 0.05 or 0.1% of MMS. Fig. 8A shows that complementation using M krk and pDB constructs in the null mutant could not reverse the phenotype of MMS hypersensitivity (Fig. 8, lanes 6 and 9) , whereas the other two mutants, M kkk and M kr , were able to reverse the null yeast phenotypes. The survival of these four different strains at MMS concentrations of 0.05 and 0.1% is displayed in Fig. 8B , which quantitatively reflects the results of Fig. 8A . Although M kkk showed a partial defect in the nuclear localization of the protein in HeLa cells, it reversed the defective phenotype of the yeast null mutant. This is probably due to the high level exogenous expression of FEN-1 nuclease and because partial localization is sufficient to support this particular biological activity.
DISCUSSION
Although biochemical and genetic analysis has provided convincing evidence for the uniqueness and importance of FEN-1 in DNA replication and repair (for recent reviews see Refs. 1 and 9 and references therein), the functional significance of nuclear localization of FEN-1 was unclear. Our studies provide evidence regarding the NLS of FEN-1 and its importance in response to the cell cycle and DNA damage. esis data indicate that removal of, or mutations in, the Cterminal last 26 amino acids did not affect flap endonuclease or nick-specific exonuclease activities or PCNA interaction (Fig.  4) . However, specific mutations abolished the nuclear localization of the nuclease (Fig. 5) . There are three clusters of positively charged amino acids in this region. Mutation of the KKK cluster partially diminished the nuclear localization in HeLa cells, whereas mutation of KRK completely abolished this activity. However, conversion of KR in the third cluster did not show any effect on nuclear localization, indicating that these two residues are not critical. KRK and KKK are separated by eight other amino acids, a distance similar to most identified bipartite NLSs, e.g. as in XPG and p53 (19, 22, 41) . Previously, Friedberg (28) and then Boulikas (42) is such that it could diffuse passively through the nuclear pores, the rate of the diffusion, based on comparison with ovalbumin, which is of similar size (43) , is likely to be too low to be practicable. Both in vitro biochemical and in vivo yeast genetic data indicated that the enzyme is involved in RNA primer removal during lagging strand DNA synthesis of DNA replication (44) and alternative PCNA-dependent long patch base excision repair (13, 14) . FEN-1, as a riboexonuclease, removes the last ribonucleotide of RNA primers after RNase H endonucleotically digests the major portion of the RNA primer during the Okazaki fragment processing. As a structure-specific flap endonuclease, it removes the DNA fragment displaced by a DNA polymerase ␦ during DNA base excision repair. Both of these processes may require a rapid transport of the nuclease from cytoplasm to nucleus in response to cellular DNA synthesis and damage.
Immunoflourescent staining of the endogenous FEN-1 proteins in different phases of the synchronized HeLa cells showed different distribution patterns (Fig. 1) . The pattern of migration correlated well with DNA synthesis. Cells in G 1 phase had little FEN nuclease localized into nuclei corresponding to the low level of DNA synthesis, whereas cells in S phase had FEN-1 exclusively localized into the nucleus. FEN-1 remained in the nuclei until cells entered the G 2 phase (Fig. 1) . In addition, upon treatment with the DNA-damaging reagent MMS, the FEN-1 protein immediately moved into the nucleus (Fig. 2 and  3 ). This presumably allowed it to function in DNA repair. The localization of FEN-1 nuclease was also observed in yeast cells transformed by FEN-1-GFP fusion constructs (data not shown). The ratio of protein in the nucleus to that in the cytoplasm has been significantly increased to a similar degree that is observed in mammalian cells. It is noteworthy that the yeast Rad27 gene 30°C ; B, 37°C; and C, cell growth curves at 37°C. Lanes 1, Wt ϩ pDB20; 2, Wt ϩM kkk -pDB; 3, Wt ϩ M krk -pDB; 4, Wt ϩ M nlsd -pDB; 5, rad27 ϩ M kkk -pDB; 6, rad27 ϩ M krk -pDB; 7, rad27 ϩ M kr -pDB; 8, rad27 ϩ FEN1-pDB; 9, rad27 ϩ pDB20. The numbers on the right sides of the A and B are dilutions of yeast cells. (lanes 1-9) represent Wt ϩ pDB20, Wt ϩ M kkk -pDB, Wt ϩ M krk -pDB, Wt ϩ M nlsd -pDB, rad27 ϩ M kkk -pDB, rad27 ϩ M krk -pDB, rad27 ϩ M kr -pDB, rad27 ϩ FEN1-pDB, and rad27 ϩ pDB20, respectively. The numbers on the right side of the A are dilutions of yeast cells.
was preferentially expressed at the G 1 /S transition and transcription was also damage-inducible (45, 46) . How signals of DNA damage and DNA synthesis activities in nuclei travel from the nucleus to the cytoplasm and activate the NLS to initiate the localization process is largely unknown. However, recent results indicate that NLS-dependent nuclear import is precisely regulated, and phosphorylation is involved. For example, phosphorylation of human retinoblastoma protein results in its cell cycle-dependent nuclear localization (47) . For the SV40 antigen, the presence of phosphorylatable sequences in the N-terminal region of the NLS increases nuclear localization efficiency. Removal of these residues decreases the nuclear uptake rate of this protein (48, 49) . In addition, the transcription factor Stat 1 is phosphorylated by the Jak family of tyrosine kinases, which results in dimer formation followed by translocation into the nucleus to activate directly target genes (50) . The phosphorylation sites, together with the NLS, constitute phosphorylation-mediated regulatory modules for nuclear protein localization. The detailed mechanism relating the signaling of DNA damage to FEN-1 migration into nuclei needs further investigation.
Defects in the NLS of FEN-1 Protein Abolish Specific in Vivo Biological Functions-Our biochemical experiments showed that deletion or alterations of the C-terminal amino acids of FEN-1 did not affect its in vitro flap endonuclease, nick-specific exonuclease, or PCNA-interaction activities (Fig. 5) . However, abolishing the nuclear localization of this protein both in mammalian and yeast cells resulted in in vivo defects of cellular DNA synthesis activities and repair of DNA damage. The wild type human enzyme could support the survival of the yeast rad27 null mutant at 37°C, whereas the M krk mutant cannot (Fig. 7) . In the latter case, cells accumulated in the S phase apparently due to failure of the nuclear localization of FEN-1 proteins. In addition, expression of wild type FEN-1 enzyme reversed the MMS sensitivity of the yeast rad27 null mutants, while localization-deficient NLS mutants had dramatically reduced recovery ability similar to the null mutants ( Fig. 7 and  8 ). Although M kkk showed a partial defect in the nuclear localization of the protein, it reversed the defective phenotype of the yeast null mutant in a similar degree to that by M kr and wild type FEN-1s. This is probably due to the high level exogenous expression of FEN-1 nuclease and because partial localization is sufficient to support the biological activities. All of these data indicate that nuclear localization is a crucial process for a biochemically active enzyme to perform its replication and repair functions in nucleus.
